JNJ

230.63

+2.12%↑

ABT

92.43

+0.79%↑

MDT

83.72

+0.54%↑

114.27

-5.32%↓

VEEV

156.08

-4.6%↓

JNJ

230.63

+2.12%↑

ABT

92.43

+0.79%↑

MDT

83.72

+0.54%↑

114.27

-5.32%↓

VEEV

156.08

-4.6%↓

JNJ

230.63

+2.12%↑

ABT

92.43

+0.79%↑

MDT

83.72

+0.54%↑

114.27

-5.32%↓

VEEV

156.08

-4.6%↓

JNJ

230.63

+2.12%↑

ABT

92.43

+0.79%↑

MDT

83.72

+0.54%↑

114.27

-5.32%↓

VEEV

156.08

-4.6%↓

JNJ

230.63

+2.12%↑

ABT

92.43

+0.79%↑

MDT

83.72

+0.54%↑

114.27

-5.32%↓

VEEV

156.08

-4.6%↓

Home・Aktien・Avita Therapeutics Inc

Avita Therapeutics Inc

Geschlossen

4.28 -7.96

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

4.28

Max

4.66

Schlüsselkennzahlen
By Trading Economics
Einkommen	1.6M -12M
Verkäufe	554K 18M
Gewinnspanne	-65.968
Angestellte	226
EBITDA	1.6M -9.7M

Empfehlungen
By TipRanks
Empfehlungen	Buy
12-Monats-Prognose	+35.55% upside

Dividenden
By Dow Jones
Nächstes Ergebnis	7. Mai 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	30M 153M
Vorheriger Eröffnungskurs	12.24
Vorheriger Schlusskurs	4.28

Technischer Score

By Trading Central

Vertrauen

Very Strong Bearish Evidence

8.83 / 9.77 Unterstützung & Widerstand

Avita Therapeutics Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

24. Apr. 2026, 00:00 UTC

Ergebnisse

Renesas Electronics 1Q Net Y68.15B Vs Net Y26.01B

24. Apr. 2026, 00:00 UTC

Ergebnisse

Renesas Electronics 1Q Net Y68.15B Vs Net Y26.01B

23. Apr. 2026, 23:47 UTC

Market Talk

Gold Edges Lower Amid Ongoing Concerns Over Higher Inflation -- Market Talk

23. Apr. 2026, 23:43 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

23. Apr. 2026, 23:43 UTC

Market Talk

Global Equities Roundup: Market Talk

23. Apr. 2026, 23:43 UTC

Market Talk

Nikkei May Decline Amid Uncertainty Over U.S.-Iran Conflict -- Market Talk

23. Apr. 2026, 23:13 UTC

Akquisitionen, Fusionen, Übernahmen

Trump on Spirit Airlines: 'I Think We'd Just Buy It' -- Update

23. Apr. 2026, 22:33 UTC

Ergebnisse

Intel Shares Jump 20% as AI Agents Drive Big Growth -- WSJ

23. Apr. 2026, 22:17 UTC

Ergebnisse

PLS Executed Offtake Agreement With Ronbay

23. Apr. 2026, 22:17 UTC

Ergebnisse

PLS Secured Up to A$38.1M in Australia Government ARENA Grant Funding

23. Apr. 2026, 22:16 UTC

Ergebnisse

PLS Commences Commissioning of Midstream Demonstration Plant

23. Apr. 2026, 22:15 UTC

Ergebnisse

PLS Group Reaffirms FY26 Guidance for All Metrics

23. Apr. 2026, 22:14 UTC

Ergebnisse

PLS Group 3Q Cash Margin From Operations A$461M at March 31

23. Apr. 2026, 22:14 UTC

Ergebnisse

PLS Group 3Q Cash Balance A$1.455 Billion at March 31

23. Apr. 2026, 22:13 UTC

Ergebnisse

PLS Group 3Q Unit Operating Cost A$733/Ton CIF, Up 2% on 2Q

23. Apr. 2026, 22:12 UTC

Ergebnisse

Correct: PLS Group 3Q Unit Operating Cost A$520/Ton FOB, Down 11% on 2Q

23. Apr. 2026, 22:12 UTC

Ergebnisse

PLS Group 3Q Unit Operating Cost US$520/Ton FOB, Down 11% on 2Q

23. Apr. 2026, 22:11 UTC

Ergebnisse

PLS Group 3Q Realized Price US$1,867/Ton, Up 61% on 2Q

23. Apr. 2026, 22:10 UTC

Ergebnisse

PLS Group 3Q Revenue A$567,000, Up 52% on 2Q

23. Apr. 2026, 22:09 UTC

Ergebnisse

PLS Group 3Q Sales 195,700 Tons, Down 16% on 2Q

23. Apr. 2026, 22:08 UTC

Ergebnisse

PLS Group 3Q Production 232,400 Tons, Up 12% on 2Q

23. Apr. 2026, 22:04 UTC

Ergebnisse

Intel Sales Rise 7% as AI Agents Drive Growth -- WSJ

23. Apr. 2026, 21:56 UTC

Market Talk

Ergebnisse

Intel Points to Growing Role of CPUs Amid AI Shifts -- Market Talk

23. Apr. 2026, 21:48 UTC

Akquisitionen, Fusionen, Übernahmen

Regeneron Shares Up on Trump Drug Pricing Deal -- Barrons.com

23. Apr. 2026, 21:27 UTC

Ergebnisse

Intel CFO: All Demand Signals Point to Growing Role of CPUs in AI Era

23. Apr. 2026, 21:25 UTC

Ergebnisse

Intel CFO Expects Factories to Continue Increasing Supply in 3Q, 4Q, but at More Measured Pace Than Previously Expected

23. Apr. 2026, 21:24 UTC

Ergebnisse

SAP Stock Rebounds From Software Slaughter. The Cloud Boosted Europe's Tech Titan. -- Barrons.com

23. Apr. 2026, 21:24 UTC

Ergebnisse

Blackstone Stock Falls After Earnings. Private Credit Remains in Focus. -- Barrons.com

23. Apr. 2026, 21:21 UTC

Ergebnisse

Intel to Look for Unconventional Way to Boost Manufacturing Capacity Through Musk's Terafab Project, CEO Says

23. Apr. 2026, 21:21 UTC

Ergebnisse

Intel CEO: He, Elon Musk Believe Global Semiconductor Supply Isn't Keeping Up With Accelerating Demand

Peer-Vergleich

Kursveränderung

Avita Therapeutics Inc Prognose

Kursziel

By TipRanks

35.55% Vorteil

12-Monats-Prognose

Durchschnitt 6.33 USD 35.55%

Hoch 10 USD

Tief 3.5 USD

Basierend auf 4 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Avita Therapeutics Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

4 ratings

Buy

Halten

Sell

Basierend auf 4 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Avita Therapeutics Inc – Dist abgegeben haben.

Technischer Score

By Trading Central

8.83 / 9.77Unterstützung & Widerstand

Recent bearish events outweigh bullish events.

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Avita Therapeutics Inc

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.